Achieving and maintaining good business performance is a core concern of every business entity. This quantitative study investigates the impact of sourcing strategies and logistics capabilities on the performance of Jordanian pharmaceutical enterprises using partial least square structural equation modeling (PLS-SEM). The views and perceptions of 951 managers and assistant manager respondents working in Jordanian pharmaceutical companies were gathered anonymously via an electronic online questionnaire using a convenience sampling technique. The findings revealed that sourcing strategies and logistical capabilities have a significant positive impact on organizational performance in pharmaceutical companies. Insourcing, near-sourcing, few / many suppliers, joint ventures, and virtual enterprises were perceived to be effective sourcing strategies in improving organizational performance. In contrast, outsourcing, and vertical integration were perceived to have a negligible impact on the performance in the context of pharmaceuticals. Furthermore, the findings confirmed that individual logistic capabilities (safety and compliance, storage, delivery, and imports and exports) of pharmaceutical firms were perceived as impacting positively on firm performance. This research provides useful insight for decision makers in pharmaceutical companies in Jordan when reviewing their supply chain, particularly during challenging and turbulent times such as the COVID-19 pandemic.

This article analyzes the impact of internal control on the performance of pharmaceutical companies, providing additional empirical evidence on the effects of internal control on performance. The research method used includes surveys through questionnaires distributed among pharmaceutical companies to assess internal control and each element of internal control of these firms. Quantitative research was carried out with SPSS 25 software. The results show that monitoring, information and communication are the factors that have the strongest impacts on the performance of pharmaceutical companies. This can be explained that, for pharmaceutical companies, good monitoring and information and good tradition will positively affect the effectiveness of internal control in particular and the performance of the business. Based on the research results, the author proposes some recommendations to improve the effectiveness of internal control, thereby contributing to improve the performance of pharmaceutical enterprises.

The purpose of this paper is to examine the association between corporate governance and Intellectual capital in the pharmaceutical companies accepted in Tehran Stock Exchange over the period 2004-2009 using a regression based model. The study investigates the impacts of three some independent variables of the corporate governance (i.e. the number of board members, the relative extent of nonexecutive to executive directors, the auditing committee). The results suggest that corporate governance had no special effect on intellectual capital in the pharmaceutical companies. Furthermore among corporate governance & apos; s variables, the first one (i.e. board size) had negative impact on firms & apos; intellectual capital and the second and the third variables had no effects on intellectual capital.